ultiple valvular heart disease (VHD), ie, the combination of stenotic or regurgitant lesions occurring on ≥2 cardiac valves, and mixed VHD, ie, the combination of stenotic and regurgitant lesions on the same valve, are highly prevalent conditions. Yet, there is only limited data in the literature and current guidelines to support and guide clinical decision-making. This paradox is, at least partly, explained by the heterogeneity of these conditions in terms of combinations, pathogenesis, severity, surgical risk, reparability, and suitability for transcatheter therapies.
PATHOGENESIS AND PREVALENCE
Multiple and mixed VHD are highly prevalent conditions. In the Euro Heart Survey, multiple VHD, as defined by at least 2 moderate VHDs, was observed in 20% of the patients with native VHD and in 17% of those undergoing intervention. 1 In the American Society of Thoracic Surgeons Database including 290 000 patients who underwent surgery between 2003 and 2007, 11% had double valve procedures (replacement or repair), most often aortic and mitral, 2 and triple valve surgery has been performed in 1% of cases. In a Swedish nationwide study based on hospital discharge codes without quantification of valvular dysfunction, multiple VHD accounted for 11% of patients. 3 The most frequent associations were aortic stenosis (AS) plus aortic regurgitation (AR), AS plus mitral regurgitation (MR) and AR plus MR.
Multiple valve disease is most often acquired. 4 In the Euro Heart Survey, 5 rheumatic fever was the predominant pathogenesis (51%), but degenerative VHD was also highly prevalent (41%). Other acquired pathogeneses, which include infective endocarditis, radiation therapy, drug-induced VHD, and inflammatory diseases, were by far less frequent. As in single VHD, a shift from rheumatic toward degenerative pathogenesis is currently observed in industrialized countries reflecting aging and the overall decreased incidence of rheumatic fever. Degenerative mitral annulus and leaflet calcifications often coexist with AS in the elderly patients and may, when severe, cause significant mitral stenosis (MS). This multiple VHD entity is often associated with worse prognosis and poses specific therapeutic challenges 6 because balloon commissurotomy or surgical mitral valve replacement is often not an option in these patients. Secondary MR and tricuspid regurgitation (TR) may develop in patients with aortic VHD and in patients with right ventricular volume or pressure overload because of left-sided or pulmonary VHD. Significant pulmonary regurgitation is unusual, and acquired pathogeneses include endocarditis, carcinoid disease, and, rarely, leftsided VHD-related pulmonary hypertension. Because of the high prevalence of coronary artery disease with previous myocardial infarction in patients with degenerative VHD, associated ischemic MR is not uncommon in this setting. Congenital pathogeneses are far less frequent causes of multiple VHD.
Congenital (mainly bicuspid aortic valve) and degenerative VHDs are currently the most frequent pathogeneses of mixed aortic VHD among patients undergoing aortic valve replacement (37%-49% and 53%, respectively) in industrialized countries, whereas rheumatic (9%-13%) and endocarditis (1%) are less frequent. 4, 5 Mixed mitral VHD mainly results from rheumatic and degenerative processes, the latter being found almost exclusively in the elderly. Although the prevalence of adult congenital heart disease is constantly increasing and many of these individuals have multiple or mixed VHD, 7 this review will focus on noncongenital multiple/ mixed VHD.
PATHOPHYSIOLOGY, DIAGNOSIS, AND IMAGING
The hemodynamic and clinical consequences of any given valvular lesion may be modulated by the concomitant presence of another stenotic or regurgitant lesion on the same valve (mixed VHD), or on another valve (multiple VHD). These consequences depend on the complex interplay of several factors, including the specific combination of VHD, the severity and timing of onset of each individual lesion, the loading conditions, and the ventricular systolic or diastolic performance. The main hemodynamic interactions that may impact on the diagnosis of multiple and mixed VHDs are (1) low-flow, low-gradient stenosis is frequent; (2) mixed valve disease may be associated with increased anterograde flow and gradient; (3) the continuity equation is inapplicable when transvalvular flows are unequal; (4) any severe valvular lesion may induce or increase upstream secondary MR or TR; (5) pressure half-timederived methods may be invalid in the presence of altered left ventricular (LV) compliance/relaxation or abnormal LV filling in the presence of mixed VHD.
Role of Imaging Modalities for Assessment of Multiple/Mixed VHD

Doppler Echocardiography
Doppler echocardiography is the cornerstone of the diagnosis of multiple and mixed VHD. As in singlevalve/single-lesion disease, echocardiography will allow establishing the pathogenesis, mechanisms, severity, progression, and repercussions of each valvular lesion.
Echocardiography is critical in determining the indication and timing for surgery and the likelihood of successful valve repair or of transcatheter valve intervention. However, the hemodynamic consequences of multiple and mixed VHD on blood flow, ventricular size, and function may affect the echocardiographic diagnosis. Several methods routinely used to assess VHD have not been validated in this subset of patients and may be misleading if not correctly interpreted in the context of the multiple/mixed VHD. The main diagnostic caveats in the echocardiographic diagnosis in multiple and mixed VHD are presented in Table 1 . 4 An integrative approach is even more needed than for single VHD.
Cardiac Catheterization
Cardiac catheterization is currently recommended in situations where noninvasive evaluation is inconclusive or discordant with clinical findings 8 and remains commonly performed in patients with multiple VHD. 1 However, cardiac output assessment by either the thermodilution or the Fick method, which is an essential component of the Gorlin formula for the calculation of aortic or mitral valve area, may be inaccurate in patients with severe TR and among those with low cardiac output, which are both common in multiple and mixed VHD. Moreover, because right heart flow does not equal the transvalvular flow in patients with mixed aortic and mixed mitral VHD, the Gorlin formula is inherently inaccurate and should not be used in this setting.
There is growing evidence that other imaging modalities can be helpful in VHD when conventional echocardiography is inconclusive. However, there is currently no data on their potential role in the specific assessment of patients with multiple VHD. Yet, an accurate determination of the severity of stenotic and regurgitant lesions is critical, and imaging techniques other than standard echocardiography may prove helpful in difficult cases, particularly in the setting of low-flow situations.
Three-Dimensional Echocardiography
Three-dimensional echocardiography can be used to obtain more accurate assessment of aortic valve area, by allowing direct measurement of LV outflow tract area (the which is usually not circular). Using a transthoracic or transesophageal approach, it may also be used to measure mitral valve area in rheumatic MS. 
Stress Echocardiography
Low-dose (≤20 µg/kg per min) dobutamine stress echocardiography may be helpful to distinguish true severe from pseudosevere AS and to assess LV flow reserve, when the pressure gradient is low and LV ejection fraction is reduced. Although there is limited (if any) specific data on multiple and mixed VHD, treadmill or preferably bicycle stress echocardiography may be indicated when symptoms appear disproportionate in relation to the resting hemodynamics. This test may provide a mechanistic explanation for the symptoms, by revealing, for example, a disproportionate increase in the transvalvular pressure gradient or pulmonary arterial pressure.
When the VHD appears severe on resting echocardiography but the patient claims to be asymptomatic, exercise testing may unmask symptoms, an abnormal blood pressure response to exercise, ST-segment abnormalities, or exercise-induced arrhythmias. This table presents the caveats in the echocardiographic assessment of a given valvular lesion (horizontal rows) in presence of concomitant valvular lesion (vertical columns) and the proposed solutions using multimodality imaging. 3D indicates 3-dimensional; AR, aortic regurgitation; AS, aortic stenosis; AVA, aortic valve area; C, caveat; CMR, cardiac magnetic resonance; DSE, dobutamine stress echocardiography; LV, left ventricular; MDCT, multidetector computed tomography; MR, mitral regurgitation; MS, mitral stenosis; PISA, proximal isovelocity surface area; and S, solution.
Adapted from Unger et al 4 with permission. Copyright © 2011.
Multidetector Computed Tomography
Multidetector computed tomography is increasingly used to assess the aortic valve calcium score when there is evidence of low-flow, low-gradient AS and preserved LV ejection fraction. High calcium scores are consistent with increased likelihood of severe AS (Table 2) .
8,13,14
Cardiac Magnetic Resonance
In patients with inadequate echocardiographic image quality or in case of discrepant results, cardiac magnetic resonance allows assessing the severity of valvular lesions, particularly of regurgitant lesions and thus of mixed valve disease, as well as ventricular volumes and systolic function. 15 However, the assessment of regurgitant fraction and volume by calculating ventricular volumes may be misleading in the presence of multiple VHD because it assumes that only one valve is affected, and alternative methods, such as phase-contrast velocity mapping, should be preferred for quantifying valvular regurgitation. 16 Using standard imaging sequences, cardiac magnetic resonance allows identifying accurately serial changes in ventricular volumes, mass, and function reflecting the global burden of valvular disease and has, therefore, the potential to contribute to determining the optimal time for surgical or transcatheter valvular intervention. However, there is only limited data on the specific added value of cardiac magnetic resonance in multiple valve disease.
AS and MR
Long-standing increased afterload, which may eventually result in hypertrophic remodeling, dilatation, or dysfunction of the LV, is a hallmark of severe AS. Consequently, secondary MR may develop as a result of leaflet tethering and mitral annular dilatation. Because of the high prevalence of concomitant coronary artery disease, ischemic MR is also not uncommon in the elderly population. Elderly patients may also present primary MR as a result of mitral annular calcifications or prolapse ( Figure 1) . 17 The association of severe degenerative AS and MR because of chordal rupture is rare but generally associated with poor LV performance. 18 As a direct consequence of the increased afterload because of AS, the transmitral systolic pressure gradient increases, therefore, leading, for any given mitral effective regurgitant orifice, to higher regurgitant volume. Moreover, the presence of significant MR may decrease the forward flow across the aortic valve ( Figure 1 ). This MR-induced low-flow state may reduce the transaortic pressure gradient and yield to an underestimation of AS severity (Table 1) . This low-flow, low-gradient AS pattern because of coexistent MR may occur with reduced (classical low-flow, low-gradient AS) or preserved (paradoxical low-flow, low-gradient AS) LV ejection fraction. 19 In the presence of MR, dobutamine stress echocardiography may fail to induce a significant increase in LV outflow and may thus not allow the confirmation of AS severity. Quantification of aortic valve calcium score by multidetector computed tomography may be useful to differentiate true versus pseudo-severe AS in these patients with low-flow, low-gradient AS and concomitant significant MR. A typical example is shown in Figure 1 .
AS and MS
This infrequent combination is usually poorly tolerated, and the reduction in cardiac output is usually greater than what is seen in isolated AS or MS. Hence, both aortic and mitral pressure gradients may be lower than expected, which can lead to underestimation of the severity of both AS and MS. Similar to MR, severe MS may lead to low LV outflow and, therefore, result in paradoxical low-flow, low-gradient AS. This highlights the need for a careful quantification of AS severity using an integrative approach, including aortic valve calcium quantification by multidetector computed tomography.
AR and MS
Whereas preload is increased by AR, it is decreased by MS. These opposing loading conditions may result in lower LV volumes compared with isolated AR. 20 In the presence of MS, the typical signs of AR, including increased pulse pressure, may be absent. 21 Figure 2 shows a patient with rheumatic heart disease and concomitant AR and MS. In such cases, both the continuity equation and pressure halftime methods are invalid to calculate mitral valve effective orifice area, because of the presence of concomitant significant (≥moderate) AR (Table 1) . Transthoracic 3-dimensional echocardiography may be used to assess mitral valve anatomic orifice area and confirm MS severity (Figure 2 ). , and the mean gradient decreased to 7 mm Hg. The patient who was in New York Heart Association class III before transcatheter valve replacement improved to class I to II 1 mo after intervention. In summary, this is a case of a patient with severe aortic stenosis who presented with a paradoxical (preserved LV ejection fraction) low-flow, low-gradient pattern. The low-flow state was, at least partly, related to the coexistence of moderate mitral regurgitation. The presence of severe aortic stenosis was confirmed by the quantification of aortic valve calcification by computed tomography. AO indicates aorta; RV, right ventricular.
AR and MR
MR associated with AR may be primary or secondary to LV remodeling as a consequence of AR. LV relaxation and compliance have been shown to influence AR pressure half-time. 22 In turn, chronic MR may lead to LV dilation and increase in LV compliance. 23 Hence, pressure halftime to assess AR severity should be interpreted cautiously in the presence of MR or in the presence of any condition altering LV relaxation/compliance. In the presence of severe MR, mild-to-moderate AR is usually well tolerated. 24 However, when AR is severe, any degree of MR may substantially worsen the LV dilation and dysfunction. AR and MR both contribute to increase preload, which may result in accelerated LV dilatation and dysfunction. Furthermore, mitral valve competency normally protects the left atrium and the pulmonary veins from the deleterious effects of the increased LV pressure related to AR. However, the coexistence of AR and MR exacerbates the impact of LV volume and pressure overload on the left atrium, pulmonary circulation, and right chambers. Hence, this combination is poorly tolerated, and postoperative LV dysfunction is more likely to occur than in isolated valve regurgitation. 25 In the long-term, LV function may eventually improve after double-valve surgery, 26 but, in a small series, persisting symptoms were more frequent than in patients undergoing valve replacement for isolated AR, and survival rates were lower compared with patients with symptomatic MR who had been operated on.
27
TR and Left-Sided VHD The prevalence of secondary TR is high among patients presenting with left-sided VHD. Although it 2 mitral valve area using the pressure half-time method. C, Continuous wave Doppler tracing across the aortic valve; mean pressure gradient was 16 mm Hg, aortic valve area was 1.5 cm 2 by continuity equation method, and the effective regurgitant orifice was 0.20 cm 2 by the proximal isovelocity surface area method (not shown). D, Three-dimensional (3D) view of the mitral valve orifice, with a 1.1-cm 2 mitral valve area using 3D reconstruction of the mitral valve orifice (E). This case highlights the overestimation of mitral valve area using the pressure half-time method in the presence of concomitant aortic valve disease. Furthermore, the continuity equation method cannot be used to calculate the mitral valve area because of the coexistence of moderate aortic regurgitation. In such situation, 3D echocardiography and planimetry of the mitral valve anatomic orifice area can be used to corroborate mitral stenosis severity. In summary, this patient had concomitant severe mitral stenosis, moderate aortic regurgitation, and mild-to-moderate aortic stenosis.
was initially mainly studied for mitral VHD, 28 there is now evidence that it may also occur as a result of aortic VHD. TR is associated with reduced long-term functional capacity and survival after treatment of the left-sided VHD. 29 A complex interplay of many factors may contribute to the occurrence and severity of secondary TR in the setting of downstream VHD, including pulmonary hypertension, atrial fibrillation, right ventricular dilatation and dysfunction, leaflet tethering, annular dilatation toward the right ventricular free wall, or right atrial enlargement. Because TR is highly sensitive to changes in loading conditions, it has been proposed that annular dilatation and leaflet coaptation, rather than TR severity itself, would be a predictor for the future development of TR and would serve as a therapeutic guide. 30 Thermodilutionderived cardiac output may be erroneously low in patients with severe TR, which may lead to underestimation of aortic valve area by the Gorlin equation and thus overestimation of AS severity. . Hence, the echocardiographic findings suggest the concomitance of a moderate aortic regurgitation with a moderate aortic stenosis. In this case, it is challenging to establish whether or not aortic valve intervention is indicated. Neither the aortic regurgitation nor the aortic stenosis is severe and mandate intervention according to the guidelines. However, (D) shows a peak velocity of 4.5 m/s and a mean gradient of 44 mm Hg. These parameters provide an assessment of the severity of the overall aortic valve disease, that is, regurgitation plus stenosis. Indeed, the peak aortic jet velocity and mean gradient increase with both aortic stenosis and aortic regurgitation (because of increase in transvalvular flow). The patient was thus referred to aortic valve replacement.
AS and AR
Mixed aortic VHD is characterized by a combination of pressure and volume load that imposes a greater stress on the LV than that induced by isolated AS or AR. The stenotic component imposes a pressure overload that aggravates LV hypertrophy, resulting in decreased LV compliance and thus in a disproportionate increase in LV diastolic pressure per unit of volume increase during diastole. 32, 33 Symptomatic patients rarely achieve a LV end-systolic dimension of 50 mm, which suggests that LV hypertrophy may not allow the LV to dilate as a result of the volume overload. [33] [34] [35] Moreover, the increase in stroke volume resulting from the regurgitant flow may further contribute to severe pressure overload even when the aortic valve area is >1.0 cm 2 . The aortic valve area reflects the severity of AS, whereas the effective regurgitant orifice area or regurgitant volume reflects the severity of AR. However, none of these parameters adequately reflects the overall hemodynamic burden associated with the summation of AS and AR. However, the peak aortic jet velocity and mean gradient increase with AS but also with AR because of increase in transvalvular flow. Hence, these parameters may be useful to assess the overall severity of the aortic valve disease (AS+AR) 34 and have been shown to correlate with the outcomes. [32] [33] [34] Hence, a symptomatic patient with moderate AS and moderate AR having a peak jet velocity ≥4 m/s and a mean gradient ≥40 mm Hg should be referred to intervention. The example of a patient presenting moderate AS combined with moderate AR resulting in a markedly increase in transaortic velocity is depicted in Figure 3 .
MS and MR
MR increases the flow rate across the mitral valve. Because transvalvular pressure gradient is a function of the square of the transvalvular flow rate, left atrial pressure may be markedly increased in patients with mixed mitral VHD, resulting in severe exercise intolerance through an increase in pulmonary venous and capillary pressure. Because of the volume overload, LV size is usually larger than in isolated MS. Similar to aortic VHD, the association of moderate MS and moderate Intervention on the tricuspid valve is usually performed at the time of intervention on the other valves in patients who are symptomatic, despite medical therapy
Balloon commissurotomy can be considered in the rare cases with anatomically suitable valves when additional MS can also be treated interventionally ACC indicates American College of Cardiology; AHA, American Heart Association; AR, aortic regurgitation; AS, aortic stenosis; AVR, aortic valve replacement; CABG, coronary artery bypass grafting; EACTS, European Association for Cardio-Thoracic Surgery; ESC, European Society of Cardiology; LOE, level of evidence; LVEF, left ventricular ejection fraction; MR, mitral regurgitation; MS, mitral stenosis; PMC, percutaneous mitral commissurotomy; TR, tricuspid regurgitation; TS, tricuspid stenosis; and VHD, valvular heart disease.
MR may be hemodynamically and clinically significant, and some patients with seemingly nonsevere mixed mitral valve disease may complain of exertional dyspnea or fatigue, which has been, at least partly, attributed to flow-dependent increases in the transmitral pressure gradient. 36 Because LV and left atrial compliances may be altered in the presence of significant MR 37 and pressure half-time is highly influenced by LV or left atrial compliance, mitral valve area derived from pressure half-time may not be reliable to assess the severity of concomitant MS. 38 The mitral valve effective orifice area measured by the continuity equation (stroke volume measured in the LV outflow tract) may overestimate the severity of MS in the presence of concomitant MR ( Table 1 ). The mitral valve anatomic orifice area measured by 3-dimensional transthoracic or transesophageal echocardiography may be used to corroborate MS severity in this context. As in patients with mixed aortic VHD, the peak transmitral velocity, mean gradient, or mitral velocity-time integral may provide an assessment of the overall severity of the mixed mitral VHD.
MANAGEMENT STRATEGY General Principles
The limited evidence on medical, surgical, and interventional management is emphasized by the C level of evidence given in most recommendations made by the American Heart Association/American College of Cardiology and European Society of Cardiology/European Association for Cardio-Thoracic Surgery guidelines (Tables 3  and 4) . 8, 10, 11 Because of the large number of possible combinations of valve lesions, a standardized approach cannot be proposed. Nevertheless, the clinician may face one of the following 3 clinical scenarios ( Figure 4) 39 : 1. Two or more severe lesions are present. In this situation, the likelihood of severe functional intolerance is high if one of the lesions is left untreated. Therefore, addressing the 2 (or more) lesions during the intervention has been given a class I recommendation in current European and American guidelines (Table 3 ). 2. One severe lesion is associated with ≥1 nonsevere lesion(s). In this common scenario, the management of the most severely diseased valve is defined by current guidelines. The management of the less-than-severe lesion(s) is less straightforward, and, in most situations, a class II recommendation has been given for intervention (Table 4) . 3. If ≥2 moderate lesions are present and if the overall hemodynamic burden imposed by these lesions is believed to be the main cause of the symptoms or LV systolic dysfunction, a surgical or transcatheter valve intervention could be considered. The latter scenario, whose exact prevalence is unknown, is not covered by current guidelines. In this setting, it is of particular importance to determine the global consequences of the lesions. This includes careful assessment of ventricular volumes and pulmonary pressure, natriuretic peptides measurements, and, in selected cases, the assessment of functional capacity, maximal oxygen consumption, and pulmonary pressure during exercise, although there is only limited literature in the specific setting of multiple valve disease. Similarly, mixed VHD may present as (1) the combination of severe stenosis and regurgitation, (2) the combination of severe stenosis (or regurgitation) and nonsevere regurgitation (or stenosis), and (3) the combination of moderate stenosis and moderate regurgitation. The first 2 scenarios should be managed following the current guideline recommendations applicable to the most severe lesion. Although the combination of aortic or mitral moderate stenosis and regurgitation is not a classical indication for intervention, this scenario may be associated with symptoms, reduced exercise tolerance, LV repercussions, and pulmonary hypertension and, thereby, intervention may be considered (Figure 4 ).
Heart Team Approach and How to Follow the Patients
A collaborative approach between cardiologists and cardiac surgeons is critical in the management of patients with multiple and mixed VHD. The situation is further complicated by the high prevalence of coronary artery disease. The Heart Team-based management strategy is now recommended by current guidelines. 8, 10, 11 The decision-making in patients with multiple and mixed VHD should be individually tai- lored, including imaging and clinical factors discussed here above.
Because of the paucity of data on its natural history, the appropriate timing for the follow-up visits of patients with multiple and mixed VHD is unclear. When one lesion is clearly predominant, the followup should be made in accordance to current guidelines. However, when severity of lesions is balanced, the combination may have detrimental consequences, and interval between follow-up visits should be shorter than in single-valve/single-lesion disease. Similarly, high event rates may be expected in patients with the combination of moderate AS and moderate AR, and more frequent serial evaluations are thus warranted. The follow-up of patients with multiple VHD should be performed in dedicated and structured outpatient heart valve clinics, 40 linked to comprehensive multidisciplinary inpatient teams, in the setting of Heart Valve Centers. 41 Whether or not leaving unoperated a less-than-severe valve lesion requires the integration of numerous factors, including the natural history of the unoperated valve and the possible changes in MR or TR severity after treatment of a downstream valvular lesion, the life expectancy and comorbidities, the individual surgical risk profile, the possibility of repair, the increased risk of redo surgery, and the feasibility of transcatheter approaches (Figures 4 and  5 ). All these factors should be integrated by the multidisciplinary heart valve team. Future studies are needed to determine whether simultaneous or staged transcatheter aortic, mitral, or tricuspid valve interventions will improve outcomes in patients with multiple VHD.
CONCLUSIONS
Multiple and mixed VHDs are highly prevalent. Whereas rheumatic heart disease remains the most prevalent pathogenesis in developing countries, degenerative pathogeneses are more prevalent in industrialized regions. Hemodynamic interactions may alter the clinical expression of each singular lesion, and the clinician should be aware of these interactions that may impact the diagnosis. Patients with multiple or mixed VHD should be followed in heart valve clinics. A case-by-case therapeutic management strategy should be made by a Heart Valve team, taking into account multiple factors, including the severity of each single valvular lesion, the individual risk profile, the increased long-term morbidity of multiple prostheses, and the natural history of each valvular lesion if left untreated (Figure 4 ). Current and future advances in transcatheter valve therapies are likely to change the therapeutic approach of multiple VHD, but there is currently no evidence-based management strategy in this setting.
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